The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib)

被引：51

作者：

von Bubnoff, Nikolas ^{[1
]}

Gorantla, Sivahari Prasad ^{[1
]}

Thoene, Silvia ^{[1
]}

Peschel, Christian ^{[1
]}

Duyster, Justus ^{[1
]}

机构：

[1] Tech Univ Munich, Dept Internal Med 3, D-81675 Munich, Germany

来源：

BLOOD | 2006年 / 107卷 / 12期

关键词：

D O I：

10.1182/blood-2006-01-0285

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4970 / 4971

页数：2

共 8 条

[1] A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome [J].

Cools, J ;

DeAngelo, DJ ;

Gotlib, J ;

Stover, EH ;

Legare, RD ;

Cortes, J ;

Kutok, J ;

Clark, J ;

Galinsky, I ;

Griffin, JD ;

Cross, NCP ;

Tefferi, A ;

Malone, J ;

Alam, R ;

Schrier, SL ;

Schmid, J ;

Rose, M ;

Vandenberghe, P ;

Verhoef, G ;

Boogaerts, M ;

Wlodarska, I ;

Kantarjian, H ;

Marynen, P ;

Coutre, SE ;

Stone, R ;

Gilliland, DG .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (13) :1201-1214

[2] Treatment of hypereosinophilic syndrome with imatinib mesilate [J].

Gleich, GJ ;

Leiferman, KM ;

Pardanani, A ;

Tefferi, A ;

Butterfield, JH .

LANCET, 2002, 359 (9317) :1577-1578

[3] Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification [J].

Gorre, ME ;

Mohammed, M ;

Ellwood, K ;

Hsu, N ;

Paquette, R ;

Rao, PN ;

Sawyers, CL .

SCIENCE, 2001, 293 (5531) :876-880

[4]

KANTARJIAN HM, 2005, ASCO, V23, pS195

[5]

OTTMANN O, 2005, ASCO, V23, pS195

[6] The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRβ and FIP1L1-PDGFRα in vitro and in vivo [J].

Stover, EH ;

Chen, J ;

Lee, BH ;

Cools, J ;

McDowell, E ;

Adelsperger, J ;

Cullen, D ;

Coburn, A ;

Moore, SA ;

Okabe, R ;

Fabbro, D ;

Manley, PW ;

Griffin, JD ;

Gilliland, DG .

BLOOD, 2005, 106 (09) :3206-3213

[7] Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia [J].

von Bubnoff, N ;

Sandherr, M ;

Schlimok, G ;

Andreesen, R ;

Peschel, C ;

Duyster, J .

LEUKEMIA, 2005, 19 (02) :286-287

[8] Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl [J].

Weisberg, E ;

Manley, PW ;

Breitenstein, W ;

Brüggen, J ;

Cowan-Jacob, SW ;

Ray, A ;

Huntly, B ;

Fabbro, D ;

Fendrich, G ;

Hall-Meyers, E ;

Kung, AL ;

Mestan, J ;

Daley, GQ ;

Callahan, L ;

Catley, L ;

Cavazza, C ;

Mohammed, A ;

Neuberg, D ;

Wright, RD ;

Gilliland, DG ;

Griffin, JD .

CANCER CELL, 2005, 7 (02) :129-141

← 1 →